×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NAMS – newamsterdam pharma company n.v. - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NAMS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/18
04:00 pm
nams
NewAmsterdam Pharma (NAMS) is now covered by Truist Financial Corporation. They set a "buy" rating and a $57.00 price target on the stock.
Low
Report
NewAmsterdam Pharma (NAMS) is now covered by Truist Financial Corporation. They set a "buy" rating and a $57.00 price target on the stock.
3/6
04:01 pm
nams
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/25
08:00 am
nams
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March
Medium
Report
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March
2/23
06:23 am
nams
The Bull Case For NewAmsterdam Pharma (NAMS) Could Change Following 2025 Results And New Share Offering [Yahoo! Finance]
Low
Report
The Bull Case For NewAmsterdam Pharma (NAMS) Could Change Following 2025 Results And New Share Offering [Yahoo! Finance]
2/20
07:27 am
nams
NewAmsterdam Pharma (NASDAQ:NAMS) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Low
Report
NewAmsterdam Pharma (NASDAQ:NAMS) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
2/19
03:08 pm
nams
NewAmsterdam Pharma (NASDAQ:NAMS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
NewAmsterdam Pharma (NASDAQ:NAMS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
2/19
08:42 am
nams
NewAmsterdam Pharma (NASDAQ:NAMS) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
NewAmsterdam Pharma (NASDAQ:NAMS) had its "buy" rating reaffirmed by analysts at Guggenheim.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/12
04:26 pm
nams
Form 4 NewAmsterdam Pharma Co For: Mar 11 Filed by: LANGE LOUIS G
Medium
Report
Form 4 NewAmsterdam Pharma Co For: Mar 11 Filed by: LANGE LOUIS G
3/11
04:09 pm
nams
Form 144 NewAmsterdam Pharma Co Filed by: LANGE LOUIS G
Medium
Report
Form 144 NewAmsterdam Pharma Co Filed by: LANGE LOUIS G
3/10
08:58 pm
nams
Form 4 NewAmsterdam Pharma Co For: Mar 06 Filed by: LANGE LOUIS G
Low
Report
Form 4 NewAmsterdam Pharma Co For: Mar 06 Filed by: LANGE LOUIS G
3/9
08:18 pm
nams
Form 4 NewAmsterdam Pharma Co For: Mar 05 Filed by: Kastelein Johannes Jacob Pieter
Medium
Report
Form 4 NewAmsterdam Pharma Co For: Mar 05 Filed by: Kastelein Johannes Jacob Pieter
3/6
05:52 pm
nams
Form 144 NewAmsterdam Pharma Co Filed by: LANGE LOUIS G
Medium
Report
Form 144 NewAmsterdam Pharma Co Filed by: LANGE LOUIS G
3/5
04:14 pm
nams
Form 144 NewAmsterdam Pharma Co Filed by: Kastelein Johannes Jacob Pieter
Low
Report
Form 144 NewAmsterdam Pharma Co Filed by: Kastelein Johannes Jacob Pieter
3/2
06:08 pm
nams
Form 4 NewAmsterdam Pharma Co For: Mar 02 Filed by: Davidson Michael H.
Medium
Report
Form 4 NewAmsterdam Pharma Co For: Mar 02 Filed by: Davidson Michael H.
3/2
04:10 pm
nams
Form 144 NewAmsterdam Pharma Co Filed by: Davidson Michael H.
Medium
Report
Form 144 NewAmsterdam Pharma Co Filed by: Davidson Michael H.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: